70 related articles for article (PubMed ID: 25209687)
1. Preparation and optimization of resveratrol nanosuspensions by antisolvent precipitation using Box-Behnken design.
Hao J; Gao Y; Zhao J; Zhang J; Li Q; Zhao Z; Liu J
AAPS PharmSciTech; 2015 Feb; 16(1):118-28. PubMed ID: 25209687
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization and antitumor activity evaluation of apigenin nanoparticles by the liquid antisolvent precipitation technique.
Wu W; Zu Y; Wang L; Wang L; Wang H; Li Y; Wu M; Zhao X; Fu Y
Drug Deliv; 2017 Nov; 24(1):1713-1720. PubMed ID: 29115900
[TBL] [Abstract][Full Text] [Related]
3.
Shariare MH; Altamimi MA; Marzan AL; Tabassum R; Jahan B; Reza HM; Rahman M; Ahsan GU; Kazi M
Saudi Pharm J; 2019 Jan; 27(1):96-105. PubMed ID: 30662312
[TBL] [Abstract][Full Text] [Related]
4. 24 Factorial Design Formulation Optimization and In vitro Characterization of Desloratadine Nanosuspension Prepared Using Antisolvent Precipitation.
El-Sebaiy MT; Alyami MH; Alyami HS; Kamal MA; Eissa N; Balata G; El-Nahas H
Curr Drug Deliv; 2024 Jun; ():. PubMed ID: 38867526
[TBL] [Abstract][Full Text] [Related]
5. Formulation and evaluation of Fluconazole Nanosuspensions: In vitro characterization and transcorneal permeability studies.
Aldosari BN; Ibrahim MA; Alqahtani Y; Abou El Ela AESF
Saudi Pharm J; 2024 Jul; 32(7):102104. PubMed ID: 38841107
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine a-nanosuspension: formulation, characterization and in vivo comparison with a marketed formulation.
Nakarani M; Patel P; Patel J; Patel P; Murthy RS; Vaghani SS
Sci Pharm; 2010; 78(2):345-61. PubMed ID: 21179351
[TBL] [Abstract][Full Text] [Related]
7. PVP/aprepitant microcapsules produced by supercritical antisolvent process.
Zhang Z; Hao G; Sun X; Wang F; Zhang D; Hu D
Sci Rep; 2024 May; 14(1):10679. PubMed ID: 38724534
[TBL] [Abstract][Full Text] [Related]
8. Preparation and in Vitro Characterization of Fatty-Acid Modified Pirarubicin Nanosuspensions Stabilized by Albumin.
Hasegawa T; Tsukigawa K; Commey K; Sakuragi M; Imoto S; Taguchi K; Nishi K; Otagiri M; Yamasaki K
Chem Pharm Bull (Tokyo); 2024; 72(1):21-27. PubMed ID: 38171901
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Anti-Inflammatory Activity of Tilianin Based on the Novel Amorphous Nanocrystals.
Sun M; Guo M; He Z; Luo Y; He X; Huang C; Yuan Y; Zhao Y; Song X; Wang X
Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794224
[TBL] [Abstract][Full Text] [Related]
10. Development of a Resveratrol Nanosuspension Using the Antisolvent Precipitation Method without Solvent Removal, Based on a Quality by Design (QbD) Approach.
Kuk DH; Ha ES; Ha DH; Sim WY; Lee SK; Jeong JS; Kim JS; Baek IH; Park H; Choi DH; Yoo JW; Jeong SH; Hwang SJ; Kim MS
Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31861173
[TBL] [Abstract][Full Text] [Related]
11. Investigation of long-term pressure on primary packaging materials and a biologic drug product for injection with a novel autoinjector concept.
Primavessy D; Piening M; Nightingale A; Jameson H; Latham M; Alexander J; Büttner S; Pfrang J; Zapf A; Oakley T; Brutsche A; Saaler-Reinhardt S
Drug Deliv Transl Res; 2024 May; ():. PubMed ID: 38727986
[TBL] [Abstract][Full Text] [Related]
12. Optimizing Nanosuspension Drug Release and Wound Healing Using a Design of Experiments Approach: Improving the Drug Delivery Potential of NDH-4338 for Treating Chemical Burns.
Roldan TL; Li S; Guillon C; Heindel ND; Laskin JD; Lee IH; Gao D; Sinko PJ
Pharmaceutics; 2024 Mar; 16(4):. PubMed ID: 38675132
[TBL] [Abstract][Full Text] [Related]
13. Development of a Resveratrol Nanoformulation for the Treatment of Diabetic Retinopathy.
Gonzalez-Perez J; Lopera-Echavarría AM; Arevalo-Alquichire S; Araque-Marín P; Londoño ME
Materials (Basel); 2024 Mar; 17(6):. PubMed ID: 38541574
[TBL] [Abstract][Full Text] [Related]
14. Development of Nanosuspension of
Jahan N; Kousar F; Rahman KU; Touqeer SI; Abbas N
J Funct Biomater; 2023 Aug; 14(8):. PubMed ID: 37623677
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotechnical, Physico-Chemical, and Antioxidant Evaluation of Newly Developed Capsule Formulations.
Ozon EA; Iuga IDM; Mititelu M; Musuc AM; Manolescu BN; Petrescu S; Cusu JP; Rusu A; Surdu VA; Oprea E; Neacșu SM; Karampelas O; Elian V
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511185
[TBL] [Abstract][Full Text] [Related]
16. Recent progress in nanotechnology-based drug carriers for resveratrol delivery.
Li C; Wang Z; Lei H; Zhang D
Drug Deliv; 2023 Dec; 30(1):2174206. PubMed ID: 36852655
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Intramuscular Bioavailability of Cannabidiol Using Nanocrystals: Formulation, In Vitro Appraisal, and Pharmacokinetics.
Fu X; Xu S; Li Z; Chen K; Fan H; Wang Y; Xie Z; Kou L; Zhang S
AAPS PharmSciTech; 2022 Mar; 23(3):85. PubMed ID: 35288801
[TBL] [Abstract][Full Text] [Related]
18. ZnO Nanoparticles of
Kaur J; Anwer MK; Sartaj A; Panda BP; Ali A; Zafar A; Kumar V; Gilani SJ; Kala C; Taleuzzaman M
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209242
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
